These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 2788726

  • 1. Screening blood test identifies subclinical beryllium disease.
    Kreiss K, Newman LS, Mroz MM, Campbell PA.
    J Occup Med; 1989 Jul; 31(7):603-8. PubMed ID: 2788726
    [Abstract] [Full Text] [Related]

  • 2. Pathologic and immunologic alterations in early stages of beryllium disease. Re-examination of disease definition and natural history.
    Newman LS, Kreiss K, King TE, Seay S, Campbell PA.
    Am Rev Respir Dis; 1989 Jun; 139(6):1479-86. PubMed ID: 2729754
    [Abstract] [Full Text] [Related]

  • 3. Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study of disease risk.
    Newman LS, Mroz MM, Balkissoon R, Maier LA.
    Am J Respir Crit Care Med; 2005 Jan 01; 171(1):54-60. PubMed ID: 15374840
    [Abstract] [Full Text] [Related]

  • 4. Beryllium disease screening in the ceramics industry. Blood lymphocyte test performance and exposure-disease relations.
    Kreiss K, Wasserman S, Mroz MM, Newman LS.
    J Occup Med; 1993 Mar 01; 35(3):267-74. PubMed ID: 8455096
    [Abstract] [Full Text] [Related]

  • 5. Reexamination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease.
    Mroz MM, Kreiss K, Lezotte DC, Campbell PA, Newman LS.
    J Allergy Clin Immunol; 1991 Jul 01; 88(1):54-60. PubMed ID: 2071785
    [Abstract] [Full Text] [Related]

  • 6. Assessment of the beryllium lymphocyte proliferation test using statistical process control.
    Cher DJ, Deubner DC, Kelsh MA, Chapman PS, Ray RM.
    Inhal Toxicol; 2006 Oct 01; 18(11):901-10. PubMed ID: 16864408
    [Abstract] [Full Text] [Related]

  • 7. Nonoccupational beryllium disease masquerading as sarcoidosis: identification by blood lymphocyte proliferative response to beryllium.
    Newman LS, Kreiss K.
    Am Rev Respir Dis; 1992 May 01; 145(5):1212-4. PubMed ID: 1586067
    [Abstract] [Full Text] [Related]

  • 8. Reversible beryllium sensitization in a prospective study of beryllium workers.
    Rom WN, Lockey JE, Bang KM, Dewitt C, Johns RE.
    Arch Environ Health; 1983 May 01; 38(5):302-7. PubMed ID: 6651355
    [Abstract] [Full Text] [Related]

  • 9. [Diagnosis of chronic berylliosis].
    Schreiber J, Zissel G, Greinert U, Galle J, Schulz KH, Schlaak M, Müller-Quernheim J.
    Pneumologie; 1999 Apr 01; 53(4):193-8. PubMed ID: 10409861
    [Abstract] [Full Text] [Related]

  • 10. Development of beryllium lymphocyte transformation tests in chronic beryllium disease.
    Williams WR, Williams WJ.
    Int Arch Allergy Appl Immunol; 1982 Apr 01; 67(2):175-80. PubMed ID: 7056594
    [Abstract] [Full Text] [Related]

  • 11. Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells.
    Saltini C, Winestock K, Kirby M, Pinkston P, Crystal RG.
    N Engl J Med; 1989 Apr 27; 320(17):1103-9. PubMed ID: 2469014
    [Abstract] [Full Text] [Related]

  • 12. Target organ localization of memory CD4(+) T cells in patients with chronic beryllium disease.
    Fontenot AP, Canavera SJ, Gharavi L, Newman LS, Kotzin BL.
    J Clin Invest; 2002 Nov 27; 110(10):1473-82. PubMed ID: 12438445
    [Abstract] [Full Text] [Related]

  • 13. Major histocompatibility locus genetic markers of beryllium sensitization and disease.
    Saltini C, Richeldi L, Losi M, Amicosante M, Voorter C, van den Berg-Loonen E, Dweik RA, Wiedemann HP, Deubner DC, Tinelli C.
    Eur Respir J; 2001 Oct 27; 18(4):677-84. PubMed ID: 11716174
    [Abstract] [Full Text] [Related]

  • 14. A Cluster of Beryllium Sensitization Traced to the Presence of Beryllium in Concrete Dust.
    Frye BC, Quartucci C, Rakete S, Grubanovic A, Höhne K, Mangold F, Gieré R, Müller-Quernheim J, Zissel G.
    Chest; 2021 Mar 27; 159(3):1084-1093. PubMed ID: 32926872
    [Abstract] [Full Text] [Related]

  • 15. Significance of the blood beryllium lymphocyte proliferation test.
    Newman LS.
    Environ Health Perspect; 1996 Oct 27; 104 Suppl 5(Suppl 5):953-6. PubMed ID: 8933041
    [Abstract] [Full Text] [Related]

  • 16. Beryllium induces IL-2 and IFN-gamma in berylliosis.
    Tinkle SS, Kittle LA, Schumacher BA, Newman LS.
    J Immunol; 1997 Jan 01; 158(1):518-26. PubMed ID: 8977230
    [Abstract] [Full Text] [Related]

  • 17. A canine model of beryllium-induced granulomatous lung disease.
    Haley PJ, Finch GL, Mewhinney JA, Harmsen AG, Hahn FF, Hoover MD, Muggenburg BA, Bice DE.
    Lab Invest; 1989 Aug 01; 61(2):219-27. PubMed ID: 2755079
    [Abstract] [Full Text] [Related]

  • 18. Blood testing for chronic beryllium disease.
    Kreiss K, Newman LS, Mroz M.
    J Occup Med; 1991 Nov 01; 33(11):1188-9. PubMed ID: 1765863
    [No Abstract] [Full Text] [Related]

  • 19. Frequency of beryllium-specific, central memory CD4+ T cells in blood determines proliferative response.
    Fontenot AP, Palmer BE, Sullivan AK, Joslin FG, Wilson CC, Maier LA, Newman LS, Kotzin BL.
    J Clin Invest; 2005 Oct 01; 115(10):2886-93. PubMed ID: 16151531
    [Abstract] [Full Text] [Related]

  • 20. [Chronic Beryllium disease after exposure to low-beryllium-content copper].
    Hasejima N, Kobayashi H, Takezawa S, Yamato K, Kadoyama C, Kawano Y.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Oct 01; 33(10):1105-10. PubMed ID: 8544383
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.